Smith & Nephew plc (NYSE:SNN) Receives Average Recommendation of “Hold” from Brokerages

Shares of Smith & Nephew plc (NYSE:SNN) have earned a consensus rating of “Hold” from the five brokerages that are covering the stock, Marketbeat reports. Three analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company.

Separately, StockNews.com upgraded Smith & Nephew from a “buy” rating to a “strong-buy” rating in a report on Friday, March 15th.

Smith & Nephew Price Performance

Shares of NYSE:SNN opened at $24.45 on Tuesday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.72 and a current ratio of 1.77. The business has a fifty day moving average of $25.99 and a two-hundred day moving average of $25.98. Smith & Nephew has a 52-week low of $21.52 and a 52-week high of $33.08.

Smith & Nephew Announces Dividend

The firm also recently declared a semi-annual dividend, which will be paid on Wednesday, May 22nd. Stockholders of record on Tuesday, April 2nd will be issued a dividend of $0.462 per share. This represents a dividend yield of 2.8%. The ex-dividend date of this dividend is Monday, April 1st.

Hedge Funds Weigh In On Smith & Nephew

Hedge funds have recently modified their holdings of the business. CWM LLC grew its holdings in shares of Smith & Nephew by 68.6% during the 4th quarter. CWM LLC now owns 954 shares of the medical equipment provider’s stock worth $26,000 after purchasing an additional 388 shares during the period. Spire Wealth Management grew its holdings in shares of Smith & Nephew by 224.3% during the 4th quarter. Spire Wealth Management now owns 1,015 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 702 shares during the period. Allworth Financial LP grew its holdings in shares of Smith & Nephew by 1,566.2% during the 3rd quarter. Allworth Financial LP now owns 1,133 shares of the medical equipment provider’s stock worth $28,000 after purchasing an additional 1,065 shares during the period. EverSource Wealth Advisors LLC grew its holdings in shares of Smith & Nephew by 75.0% during the 4th quarter. EverSource Wealth Advisors LLC now owns 1,227 shares of the medical equipment provider’s stock worth $33,000 after purchasing an additional 526 shares during the period. Finally, Parallel Advisors LLC grew its holdings in shares of Smith & Nephew by 150.9% during the 4th quarter. Parallel Advisors LLC now owns 1,533 shares of the medical equipment provider’s stock worth $42,000 after purchasing an additional 922 shares during the period. 25.64% of the stock is currently owned by hedge funds and other institutional investors.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.